The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
The FTC’s complaint, filed in its administrative court, accuses Express Scripts, Caremark Rx and Optum Rx of “abusing their ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The FTC filed a lawsuit on Friday, alleging three largest pharmacy benefit managers “artificially" inflated the cost of ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients toward higher-priced insulin in order to reap ...
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...
According to the FTC, the three largest PBMs — CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx — used their power to exclude cheaper insulin products from the menu of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback